These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 25497361)

  • 1. Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes.
    Weber T; Charusanti P; Musiol-Kroll EM; Jiang X; Tong Y; Kim HU; Lee SY
    Trends Biotechnol; 2015 Jan; 33(1):15-26. PubMed ID: 25497361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-Scale Metabolic Reconstruction of Actinomycetes for Antibiotics Production.
    Mohite OS; Weber T; Kim HU; Lee SY
    Biotechnol J; 2019 Jan; 14(1):e1800377. PubMed ID: 30117679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic biology of secondary metabolite biosynthesis in actinomycetes: Engineering precursor supply as a way to optimize antibiotic production.
    Wohlleben W; Mast Y; Muth G; Röttgen M; Stegmann E; Weber T
    FEBS Lett; 2012 Jul; 586(15):2171-6. PubMed ID: 22710162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic biology and metabolic engineering of actinomycetes for natural product discovery.
    Palazzotto E; Tong Y; Lee SY; Weber T
    Biotechnol Adv; 2019 Nov; 37(6):107366. PubMed ID: 30853630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chapter 5. Applying the genetics of secondary metabolism in model actinomycetes to the discovery of new antibiotics.
    van Wezel GP; McKenzie NL; Nodwell JR
    Methods Enzymol; 2009; 458():117-41. PubMed ID: 19374981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triggers and cues that activate antibiotic production by actinomycetes.
    Zhu H; Sandiford SK; van Wezel GP
    J Ind Microbiol Biotechnol; 2014 Feb; 41(2):371-86. PubMed ID: 23907251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic engineering of natural product biosynthesis in actinobacteria.
    Bilyk O; Luzhetskyy A
    Curr Opin Biotechnol; 2016 Dec; 42():98-107. PubMed ID: 27058643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic engineering of antibiotic-producing actinomycetes using in vitro transposon mutagenesis.
    Reeves AR; Weber JM
    Methods Mol Biol; 2012; 834():153-75. PubMed ID: 22144359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplexed site-specific genome engineering for overproducing bioactive secondary metabolites in actinomycetes.
    Li L; Zheng G; Chen J; Ge M; Jiang W; Lu Y
    Metab Eng; 2017 Mar; 40():80-92. PubMed ID: 28088540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renaissance in antibacterial discovery from actinomycetes.
    Baltz RH
    Curr Opin Pharmacol; 2008 Oct; 8(5):557-63. PubMed ID: 18524678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene networks that regulate secondary metabolism in actinomycetes: pleiotropic regulators].
    Rabyk MV; Ostash BO; Fedorenko VO
    Tsitol Genet; 2014; 48(1):67--82. PubMed ID: 24791475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Genome Mining for Metabolites Encoded by Large Gene Clusters through Heterologous Expression of a Whole-Genome Bacterial Artificial Chromosome Library in Streptomyces spp.
    Xu M; Wang Y; Zhao Z; Gao G; Huang SX; Kang Q; He X; Lin S; Pang X; Deng Z; Tao M
    Appl Environ Microbiol; 2016 Oct; 82(19):5795-805. PubMed ID: 27451447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and advances in genetic manipulation of filamentous actinomycetes - the remarkable producers of specialized metabolites.
    Musiol-Kroll EM; Tocchetti A; Sosio M; Stegmann E
    Nat Prod Rep; 2019 Sep; 36(9):1351-1369. PubMed ID: 31517370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development and application of ribosomal engineering in actinomycetes].
    Xie Y; Yao S; Li W; Shan R; Wu G; Tong T; Chen Q
    Sheng Wu Gong Cheng Xue Bao; 2022 Feb; 38(2):546-564. PubMed ID: 35234381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare actinomycetes: a potential storehouse for novel antibiotics.
    Tiwari K; Gupta RK
    Crit Rev Biotechnol; 2012 Jun; 32(2):108-32. PubMed ID: 21619453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in the Heterologous Production of Antibiotics in Streptomyces.
    Bekiesch P; Basitta P; Apel AK
    Arch Pharm (Weinheim); 2016 Aug; 349(8):594-601. PubMed ID: 27258165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic production by actinomycetes: the Janus faces of regulation.
    Cundliffe E
    J Ind Microbiol Biotechnol; 2006 Jul; 33(7):500-6. PubMed ID: 16463161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of molecular biology for the discovery of biosynthetic genes of polyketide and peptide antibiotics produced by actinomycetes].
    Kotowska M
    Postepy Biochem; 2005; 51(3):345-52. PubMed ID: 16381179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic manipulation of secondary metabolite biosynthesis for improved production in Streptomyces and other actinomycetes.
    Baltz RH
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):343-70. PubMed ID: 26364200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and molecular engineering of sugar-containing natural product biosynthetic pathways in actinomycetes.
    Oh TJ; Mo SJ; Yoon YJ; Sohng JK
    J Microbiol Biotechnol; 2007 Dec; 17(12):1909-21. PubMed ID: 18167436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.